The implication is clear: monthly attrition is a critical metric, and obesity GLP-1s face a steeper slope due to a combination of clinical ambiguity, payer friction, and patient psychology
Is switching from Ozempic/Wegovy to Mounjaro/Zepbound the same thing
However, this normalization comes with concerns
After the plasma membrane carrier-mediated GSH release from the cell, GSH becomes accessible to the active site of - glutamyl transpeptidase, which catalyzes the breakdown of the GSH - glutamyl bond forming two fractions: The -glutamyl fraction and the cysteinyl-glycine by transferring the -glutamyl fraction to an amino acid acceptor, forming -glutamyl-amino acid
Meanwhile, it also wants Lilly to conduct prospective, registry-based studies looking at safety in children and adolescents, pregnancy, and medullary thyroid cancer, as simply monitoring spontaneous postmarketing adverse events is not considered adequate for these purposes
Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug